Benitec Biopharma Limited Net Current Asset Value

Net Current Asset Value of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Current Asset Value growth rates and interactive chart.


Highlights and Quick Summary

  • Net Current Asset Value for the quarter ending March 31, 2023 was $3.89 Million (a -51.79% decrease compared to previous quarter)
  • Year-over-year quarterly Net Current Asset Value increased by 124.87%
  • Annual Net Current Asset Value for 2022 was $1.73 Million (a 0.0% decrease from previous year)
  • Annual Net Current Asset Value for 2022 was $1.73 Million (a -91.01% decrease from previous year)
  • Annual Net Current Asset Value for 2021 was $19.2 Million (a 0.0% decrease from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Current Asset Value of Benitec Biopharma Limited

Most recent Net Current Asset Valueof BNTC including historical data for past 10 years.

Interactive Chart of Net Current Asset Value of Benitec Biopharma Limited

Benitec Biopharma Limited Net Current Asset Value for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $3.89
2022 $8.06 $13.58 $1.73 $6.3 $1.73
2021 $9.49 $14.01 $19.24 $9.91 $19.24
2020 $13.5 $6.88 $9.46 $11.48 $9.46
2019 $13.94 $16.12
2018 $14.19
2017 $14.44 $15.83
2016 $14.59 $13.35 $17.51 $13.35
2015 $19.3 $19.61 $19.61
2014 $24.99 $30.76 $30.76
2013 $0.62 $0.63

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology